US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Viridian Therapeutics, Inc.

18.34

+0.06000.33%

Volume:2.44M

Turnover:44.32M

Market Cap:2.08B

PE:-5.30

High:18.44

Open:18.02

Low:17.59

Close:18.28

52wk High:34.29

52wk Low:13.18

Shares:113.29M

Float Shares:101.00M

Volume Ratio:1.07

T/O Rate:2.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4579

EPS(LYR):-3.3245

ROE:-65.74%

ROA:-30.16%

PB:3.68

PE(LYR):-5.52

Loading ...

Overview Company News Filings

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Henry Schein (HSIC), Viridian Therapeutics (VRDN) and Q32 Bio (QTTB)

Viridian Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Viridian eye disease drug surpasses expectations in late-stage trial; shares soar

Viridian Therapeutics Shares Jump 26% Premarket After Co's Eye Disease Drug Meets Main of a Late-Stage Trial in Chronic Patients

THOMSON REUTERS

Viridian announces REVEAL-2 phase 3 study met primary endpoint

Viridian Q1 FY26 net loss widens to $104.9 million; revenue rises to $141,000

Viridian says elegrobart meets Phase 3 endpoint in chronic thyroid eye disease trial

BRIEF-Viridian Therapeutics Q1 Revenue USD 6 Thousand Vs. IBES Estimate USD 27.5 Thousand

Corrected-Viridian Therapeutics Q1 Revenue USD 141 Thousand

THOMSON REUTERS

Viridian Therapeutics Q1 Revenue USD 6 Thousand VS. Ibes Estimate USD 27.5 Thousand

THOMSON REUTERS

Viridian Therapeutics Inc - Elegrobart Bla Submission on Track for Q1 2027

THOMSON REUTERS

Viridian Therapeutics Inc - Veligrotug FDA Priority Review With Pdufa Target Date June 30, 2026

THOMSON REUTERS

Viridian Therapeutics Inc - Reveal-2 Trial Meets Primary Endpoint With Highly Statistically Significant Treatment Effect

THOMSON REUTERS

Viridian Therapeutics Inc - Elegrobart Generally Well Tolerated With Low Rates of Hearing Impairment

THOMSON REUTERS

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR) and Viridian Therapeutics (VRDN)

Need To Know: The Consensus Just Cut Its Viridian Therapeutics, Inc. (NASDAQ:VRDN) Estimates For 2026

Simply Wall St.

Will Amgen’s Subcutaneous Tepezza Success Reshape Viridian Therapeutics' (VRDN) Thyroid Eye Disease Narrative?

Simply Wall St.

Viridian Therapeutics announces annual shareholder meeting webcast

A Look At Viridian Therapeutics (VRDN) Valuation After Positive REVEAL-1 Phase 3 Elegrobart Results

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/VRDN/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VRDN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRDN\",,,,,undefined,":{"symbol":"VRDN","market":"US","secType":"STK","nameCN":"Viridian Therapeutics, Inc.","latestPrice":18.34,"timestamp":1791489600000,"preClose":18.28,"halted":0,"volume":2443771,"delay":0,"changeRate":0.003282275711159667,"floatShares":101000000,"shares":113292269,"eps":-3.45791,"marketStatus":"Pre-Mkt","change":0.06,"latestTime":"10-09 09:23:29 EDT","open":18.02,"high":18.44,"low":17.59,"amount":44319395.086318,"amplitude":0.046499,"askPrice":18.69,"askSize":74,"bidPrice":18.01,"bidSize":74,"shortable":3,"etf":0,"ttmEps":-3.45791,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":18.34,"postHourTrading":{"tag":"盘后","latestPrice":18.34,"preClose":18.34,"latestTime":"19:30 EDT","volume":23282,"amount":426992.42,"timestamp":1791502203408,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0690212360129312,"impliedVol":1.6853,"impliedVolPercentile":0.956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRDN\",,,,,undefined,":{"symbol":"VRDN","floatShares":101000000,"roa":"-30.16%","roe":"-65.74%","lyrEps":-3.324491,"volumeRatio":1.0690212360129312,"shares":113292269,"dividePrice":0,"high":18.44,"amplitude":0.046499,"preClose":18.28,"low":17.59,"week52Low":13.18,"pbRate":"3.68","psRate":"29.21","week52High":34.29,"institutionHeld":0,"latestPrice":18.34,"eps":-3.45791,"divideRate":0,"volume":2443771,"delay":0,"ttmEps":-3.45791,"open":18.02,"prevYearClose":31.12,"prevWeekClose":19.4,"prevMonthClose":20.59,"prevQuarterClose":20.59,"fiveDayClose":18.99,"twentyDayClose":22.29,"sixtyDayClose":19.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRDN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"VRDN","fiscalQuarterEnding":"2026/06","expectedEps":-0.97,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-1.05},{"market":"US","date":"2026-05-05","symbol":"VRDN","fiscalQuarterEnding":"2026/03","expectedEps":-1.06,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2026-02-26","symbol":"VRDN","fiscalQuarterEnding":"2025/12","expectedEps":-0.9,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-1.08},{"market":"US","date":"2025-11-05","symbol":"VRDN","fiscalQuarterEnding":"2025/09","expectedEps":-0.82,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2025-08-06","symbol":"VRDN","fiscalQuarterEnding":"2025/06","expectedEps":1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRDN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRDN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3529,"buy":0.6471,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6471,"analysts":17,"updateTime":1782792000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRDN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRDN","date":"2026-10-08","current":-5.303782,"percent":0.463355,"low":-13.388191,"twenty":-8.20935,"median":-5.120956,"eighty":-3.854569,"high":-2.042144,"avg":-5.819215,"sd":2.415928,"marketCap":2070982677},"quantilePoints":[{"date":"2021-10-15","current":-2.227438,"twenty":-6.089421,"median":-1.847873,"eighty":-0.887883,"marketCap":295491924},{"date":"2021-10-22","current":-2.111303,"twenty":-6.087207,"median":-1.870598,"eighty":-0.892871,"marketCap":280085491},{"date":"2021-10-29","current":-2.361841,"twenty":-6.069499,"median":-1.894655,"eighty":-0.895488,"marketCap":313321841},{"date":"2021-11-05","current":-2.921254,"twenty":-6.018588,"median":-1.939373,"eighty":-0.895841,"marketCap":412507407},{"date":"2021-11-12","current":-2.952021,"twenty":-5.982617,"median":-2.013109,"eighty":-0.895841,"marketCap":416851877},{"date":"2021-11-19","current":-2.992017,"twenty":-5.958822,"median":-2.045809,"eighty":-0.898466,"marketCap":422499688},{"date":"2021-11-26","current":-2.815111,"twenty":-5.920891,"median":-2.083569,"eighty":-0.900293,"marketCap":397518986},{"date":"2021-12-03","current":-2.89818,"twenty":-5.804851,"median":-2.095645,"eighty":-0.902608,"marketCap":409249055},{"date":"2021-12-10","current":-3.153539,"twenty":-5.720757,"median":-2.112136,"eighty":-0.903933,"marketCap":445308154},{"date":"2021-12-17","current":-3.162769,"twenty":-5.684717,"median":-2.124804,"eighty":-0.904228,"marketCap":446611495},{"date":"2021-12-23","current":-3.307371,"twenty":-5.627053,"median":-2.136493,"eighty":-0.905383,"marketCap":467030503},{"date":"2021-12-31","current":-3.041243,"twenty":-5.557376,"median":-2.144389,"eighty":-0.907202,"marketCap":429450839},{"date":"2022-01-07","current":-3.076624,"twenty":-5.545363,"median":-2.155669,"eighty":-0.907579,"marketCap":434446980},{"date":"2022-01-14","current":-3.076624,"twenty":-5.504517,"median":-2.159795,"eighty":-0.909214,"marketCap":434446980},{"date":"2022-01-21","current":-2.690508,"twenty":-5.44445,"median":-2.163499,"eighty":-0.911625,"marketCap":379923884},{"date":"2022-01-28","current":-2.819726,"twenty":-5.386787,"median":-2.167548,"eighty":-0.912939,"marketCap":398170657},{"date":"2022-02-04","current":-3.041243,"twenty":-5.30029,"median":-2.168191,"eighty":-0.914935,"marketCap":429450839},{"date":"2022-02-11","current":-3.102775,"twenty":-5.259444,"median":-2.174386,"eighty":-0.915713,"marketCap":438139779},{"date":"2022-02-18","current":-2.707429,"twenty":-5.237821,"median":-2.176769,"eighty":-0.919624,"marketCap":382313342},{"date":"2022-02-25","current":-2.876643,"twenty":-5.189767,"median":-2.180535,"eighty":-0.922817,"marketCap":406207926},{"date":"2022-03-04","current":-2.616669,"twenty":-5.165741,"median":-2.184377,"eighty":-0.923707,"marketCap":369497156},{"date":"2022-03-11","current":-6.552298,"twenty":-5.189767,"median":-2.194837,"eighty":-0.924357,"marketCap":520337638},{"date":"2022-03-18","current":-6.526193,"twenty":-5.406008,"median":-2.205328,"eighty":-0.928044,"marketCap":518264580},{"date":"2022-03-25","current":-6.61756,"twenty":-5.562181,"median":-2.211127,"eighty":-0.932198,"marketCap":525520284},{"date":"2022-04-01","current":-6.095464,"twenty":-5.742381,"median":-2.218304,"eighty":-0.932257,"marketCap":484059117},{"date":"2022-04-08","current":-6.06936,"twenty":-5.964941,"median":-2.225474,"eighty":-0.936527,"marketCap":481986059},{"date":"2022-04-14","current":-6.190094,"twenty":-5.982617,"median":-2.237286,"eighty":-0.942797,"marketCap":491573954},{"date":"2022-04-22","current":-5.034958,"twenty":-5.967259,"median":-2.253314,"eighty":-0.944918,"marketCap":399841123},{"date":"2022-04-29","current":-4.707683,"twenty":-5.956504,"median":-2.270917,"eighty":-0.946466,"marketCap":373851246},{"date":"2022-05-06","current":-3.482864,"twenty":-5.909723,"median":-2.282243,"eighty":-0.947207,"marketCap":276584715},{"date":"2022-05-13","current":-4.357717,"twenty":-5.873349,"median":-2.284051,"eighty":-0.947781,"marketCap":377578758},{"date":"2022-05-20","current":-4.377056,"twenty":-5.833111,"median":-2.286158,"eighty":-0.949254,"marketCap":379254404},{"date":"2022-05-27","current":-3.929036,"twenty":-5.806354,"median":-2.291203,"eighty":-0.953515,"marketCap":340435286},{"date":"2022-06-03","current":-3.845234,"twenty":-5.766143,"median":-2.300851,"eighty":-0.95564,"marketCap":333174156},{"date":"2022-06-10","current":-3.503579,"twenty":-5.738553,"median":-2.314425,"eighty":-0.957457,"marketCap":303571088},{"date":"2022-06-17","current":-3.487463,"twenty":-5.718205,"median":-2.322868,"eighty":-0.95816,"marketCap":302174716},{"date":"2022-06-24","current":-3.53581,"twenty":-5.691925,"median":-2.327738,"eighty":-0.95986,"marketCap":306363830},{"date":"2022-07-01","current":-3.448785,"twenty":-5.644581,"median":-2.335206,"eighty":-0.962697,"marketCap":298823426},{"date":"2022-07-08","current":-3.967714,"twenty":-5.597236,"median":-2.337048,"eighty":-0.963294,"marketCap":343786577},{"date":"2022-07-15","current":-4.341601,"twenty":-5.559778,"median":-2.338078,"eighty":-0.964002,"marketCap":376182387},{"date":"2022-07-22","current":-4.180443,"twenty":-5.547765,"median":-2.361841,"eighty":-0.964772,"marketCap":362218676},{"date":"2022-07-29","current":-4.267469,"twenty":-5.536061,"median":-2.36967,"eighty":-0.968337,"marketCap":369759080},{"date":"2022-08-05","current":-4.399618,"twenty":-5.512961,"median":-2.376767,"eighty":-0.973414,"marketCap":381209323},{"date":"2022-08-12","current":-4.74772,"twenty":-5.44445,"median":-2.38391,"eighty":-0.97478,"marketCap":411370940},{"date":"2022-08-19","current":-9.166514,"twenty":-5.559778,"median":-2.389755,"eighty":-0.977513,"marketCap":899904148},{"date":"2022-08-26","current":-9.353109,"twenty":-5.730069,"median":-2.39394,"eighty":-0.980761,"marketCap":918222808},{"date":"2022-09-02","current":-8.540641,"twenty":-5.858564,"median":-2.408502,"eighty":-0.982448,"marketCap":838460311},{"date":"2022-09-09","current":-9.213243,"twenty":-5.964941,"median":-2.417029,"eighty":-0.983268,"marketCap":904491717},{"date":"2022-09-16","current":-8.940951,"twenty":-6.065072,"median":-2.431316,"eighty":-0.988194,"marketCap":877759938},{"date":"2022-09-23","current":-8.408558,"twenty":-6.095464,"median":-2.440407,"eighty":-0.989742,"marketCap":825493323},{"date":"2022-09-30","current":-8.335404,"twenty":-6.16468,"median":-2.461901,"eighty":-0.999812,"marketCap":818311651},{"date":"2022-10-07","current":-8.193162,"twenty":-6.190094,"median":-2.470279,"eighty":-1.003794,"marketCap":804347288},{"date":"2022-10-14","current":-8.522351,"twenty":-6.23079,"median":-2.490182,"eighty":-1.003794,"marketCap":836664813},{"date":"2022-10-21","current":-8.132201,"twenty":-6.282982,"median":-2.504077,"eighty":-1.004901,"marketCap":798362561},{"date":"2022-10-28","current":-8.140329,"twenty":-6.355062,"median":-2.525477,"eighty":-1.005592,"marketCap":799160525},{"date":"2022-11-04","current":-7.994023,"twenty":-6.410869,"median":-2.544309,"eighty":-1.006984,"marketCap":784797180},{"date":"2022-11-11","current":-8.335404,"twenty":-6.490499,"median":-2.57213,"eighty":-1.011563,"marketCap":818311651},{"date":"2022-11-18","current":-8.029354,"twenty":-6.526193,"median":-2.579376,"eighty":-1.01269,"marketCap":907597992},{"date":"2022-11-25","current":-8.121932,"twenty":-6.557602,"median":-2.581259,"eighty":-1.016023,"marketCap":918062536},{"date":"2022-12-02","current":-9.791895,"twenty":-6.597216,"median":-2.583049,"eighty":-1.017309,"marketCap":1106826820},{"date":"2022-12-09","current":-9.631664,"twenty":-6.662022,"median":-2.606651,"eighty":-1.020119,"marketCap":1088715108},{"date":"2022-12-16","current":-9.927201,"twenty":-6.705853,"median":-2.612477,"eighty":-1.022346,"marketCap":1122121154},{"date":"2022-12-23","current":-10.532518,"twenty":-6.753906,"median":-2.618207,"eighty":-1.026392,"marketCap":1190543175},{"date":"2022-12-30","current":-10.400773,"twenty":-6.800041,"median":-2.626049,"eighty":-1.028873,"marketCap":1175651324},{"date":"2023-01-06","current":-9.777652,"twenty":-6.800041,"median":-2.626049,"eighty":-1.028873,"marketCap":1105216890},{"date":"2023-01-13","current":-12.900376,"twenty":-6.800041,"median":-2.626049,"eighty":-1.028873,"marketCap":1458194025},{"date":"2023-01-20","current":-12.804238,"twenty":-6.813958,"median":-2.626049,"eighty":-1.028873,"marketCap":1447326998},{"date":"2023-01-27","current":-12.935983,"twenty":-6.839404,"median":-2.626049,"eighty":-1.028873,"marketCap":1462218849},{"date":"2023-02-03","current":-13.345462,"twenty":-6.905704,"median":-2.626049,"eighty":-1.028873,"marketCap":1508504335},{"date":"2023-02-10","current":-11.828609,"twenty":-6.963911,"median":-2.626049,"eighty":-1.028873,"marketCap":1337046798},{"date":"2023-02-17","current":-11.739592,"twenty":-7.06385,"median":-2.626049,"eighty":-1.028873,"marketCap":1326984736},{"date":"2023-02-24","current":-11.714667,"twenty":-7.080669,"median":-2.626049,"eighty":-1.028873,"marketCap":1324167359},{"date":"2023-03-03","current":-11.736031,"twenty":-7.164762,"median":-2.626049,"eighty":-1.028873,"marketCap":1326582254},{"date":"2023-03-10","current":-9.383947,"twenty":-7.275334,"median":-2.626049,"eighty":-1.028873,"marketCap":1218730787},{"date":"2023-03-17","current":-9.066855,"twenty":-7.275334,"median":-2.626049,"eighty":-1.028873,"marketCap":1177548754},{"date":"2023-03-24","current":-8.502035,"twenty":-7.275334,"median":-2.626049,"eighty":-1.028873,"marketCap":1104193258},{"date":"2023-03-31","current":-8.402943,"twenty":-7.28009,"median":-2.627292,"eighty":-1.029396,"marketCap":1091323873},{"date":"2023-04-06","current":-8.231185,"twenty":-7.28009,"median":-2.627292,"eighty":-1.029396,"marketCap":1069016938},{"date":"2023-04-14","current":-8.667187,"twenty":-7.275334,"median":-2.626049,"eighty":-1.028873,"marketCap":1125642234},{"date":"2023-04-21","current":-9.492948,"twenty":-7.28009,"median":-2.626049,"eighty":-1.028873,"marketCap":1232887111},{"date":"2023-04-28","current":-9.165947,"twenty":-7.28009,"median":-2.626049,"eighty":-1.028873,"marketCap":1190418140},{"date":"2023-05-05","current":-9.11144,"twenty":-7.28009,"median":-2.626049,"eighty":-1.028873,"marketCap":1183339222},{"date":"2023-05-12","current":-5.966384,"twenty":-7.218934,"median":-2.626049,"eighty":-1.028873,"marketCap":1028198864},{"date":"2023-05-19","current":-5.648973,"twenty":-7.080669,"median":-2.626049,"eighty":-1.028873,"marketCap":973498899},{"date":"2023-05-26","current":-5.959329,"twenty":-7.049434,"median":-2.626049,"eighty":-1.028873,"marketCap":1026983110},{"date":"2023-06-02","current":-6.132027,"twenty":-6.943717,"median":-2.626049,"eighty":-1.028873,"marketCap":1056744486},{"date":"2023-06-09","current":-6.374805,"twenty":-6.859623,"median":-2.626049,"eighty":-1.028873,"marketCap":1098582941},{"date":"2023-06-16","current":-6.975494,"twenty":-6.78514,"median":-2.626049,"eighty":-1.028873,"marketCap":1202100768},{"date":"2023-06-23","current":-6.672647,"twenty":-6.747315,"median":-2.623667,"eighty":-1.028351,"marketCap":1149910530},{"date":"2023-06-30","current":-5.991866,"twenty":-6.672071,"median":-2.621284,"eighty":-1.027828,"marketCap":1032590326},{"date":"2023-07-07","current":-5.826677,"twenty":-6.602877,"median":-2.621284,"eighty":-1.027828,"marketCap":1004122923},{"date":"2023-07-14","current":-5.361144,"twenty":-6.531414,"median":-2.621284,"eighty":-1.027828,"marketCap":923896607},{"date":"2023-07-21","current":-5.13088,"twenty":-6.494902,"median":-2.621284,"eighty":-1.027828,"marketCap":884214774},{"date":"2023-07-28","current":-4.628551,"twenty":-6.381669,"median":-2.621284,"eighty":-1.027828,"marketCap":797647500},{"date":"2023-08-04","current":-4.608184,"twenty":-6.342478,"median":-2.621284,"eighty":-1.027828,"marketCap":794137500},{"date":"2023-08-11","current":-4.307348,"twenty":-6.269528,"median":-2.621284,"eighty":-1.027828,"marketCap":852441464},{"date":"2023-08-18","current":-4.20143,"twenty":-6.226635,"median":-2.621284,"eighty":-1.027828,"marketCap":831479789},{"date":"2023-08-25","current":-4.148471,"twenty":-6.182084,"median":-2.621284,"eighty":-1.027828,"marketCap":820998951},{"date":"2023-09-01","current":-4.009453,"twenty":-6.136032,"median":-2.621284,"eighty":-1.027828,"marketCap":793486752},{"date":"2023-09-08","current":-4.133024,"twenty":-6.08145,"median":-2.621284,"eighty":-1.027828,"marketCap":817942040},{"date":"2023-09-15","current":-3.866022,"twenty":-5.991866,"median":-2.621284,"eighty":-1.027828,"marketCap":765101150},{"date":"2023-09-22","current":-3.473241,"twenty":-5.955324,"median":-2.621284,"eighty":-1.027828,"marketCap":687368271},{"date":"2023-09-29","current":-3.345256,"twenty":-5.863774,"median":-2.621284,"eighty":-1.027828,"marketCap":662039580},{"date":"2023-10-06","current":-3.208445,"twenty":-5.824627,"median":-2.619746,"eighty":-1.027306,"marketCap":634964082},{"date":"2023-10-13","current":-2.68106,"twenty":-5.779123,"median":-2.619746,"eighty":-1.027306,"marketCap":530592407},{"date":"2023-10-20","current":-2.595001,"twenty":-5.734071,"median":-2.616,"eighty":-1.027306,"marketCap":513561046},{"date":"2023-10-27","current":-2.795804,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":553300889},{"date":"2023-11-03","current":-3.10694,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":614875810},{"date":"2023-11-10","current":-3.602354,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":712920242},{"date":"2023-11-17","current":-3.689243,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":799307792},{"date":"2023-11-24","current":-3.958655,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":857678296},{"date":"2023-12-01","current":-4.063022,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":880290292},{"date":"2023-12-08","current":-4.512042,"twenty":-5.734843,"median":-2.610036,"eighty":-1.025477,"marketCap":977574465},{"date":"2023-12-15","current":-4.694077,"twenty":-5.734843,"median":-2.610036,"eighty":-1.025477,"marketCap":1017013994},{"date":"2023-12-22","current":-5.186785,"twenty":-5.734843,"median":-2.612889,"eighty":-1.025477,"marketCap":1123763653},{"date":"2023-12-29","current":-5.434353,"twenty":-5.735229,"median":-2.616669,"eighty":-1.024563,"marketCap":1177401413},{"date":"2024-01-05","current":-5.339694,"twenty":-5.735615,"median":-2.613558,"eighty":-1.023648,"marketCap":1156892858},{"date":"2024-01-12","current":-5.536292,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1199487549},{"date":"2024-01-19","current":-4.888248,"twenty":-5.752307,"median":-2.610447,"eighty":-1.022734,"marketCap":1059082825},{"date":"2024-01-26","current":-5.425414,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1175464692},{"date":"2024-02-02","current":-5.513632,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1194577940},{"date":"2024-02-09","current":-4.951241,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1072730990},{"date":"2024-02-16","current":-5.301357,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1148586689},{"date":"2024-02-23","current":-4.959512,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1074522857},{"date":"2024-03-01","current":-4.939896,"twenty":-5.747015,"median":-2.616669,"eighty":-1.024563,"marketCap":1174381234},{"date":"2024-03-08","current":-5.111512,"twenty":-5.747015,"median":-2.621284,"eighty":-1.024563,"marketCap":1215180155},{"date":"2024-03-15","current":-4.55442,"twenty":-5.747015,"median":-2.63799,"eighty":-1.024563,"marketCap":1082740582},{"date":"2024-03-22","current":-4.958378,"twenty":-5.747015,"median":-2.63799,"eighty":-1.024563,"marketCap":1178774964},{"date":"2024-03-28","current":-4.623067,"twenty":-5.747015,"median":-2.63799,"eighty":-1.024563,"marketCap":1099060150},{"date":"2024-04-05","current":-4.308878,"twenty":-5.749661,"median":-2.638754,"eighty":-1.023648,"marketCap":1024366742},{"date":"2024-04-12","current":-4.279835,"twenty":-5.749661,"median":-2.638754,"eighty":-1.023648,"marketCap":1017462309},{"date":"2024-04-19","current":-4.002609,"twenty":-5.749661,"median":-2.655735,"eighty":-1.023648,"marketCap":951556361},{"date":"2024-04-26","current":-3.35311,"twenty":-5.747015,"median":-2.666786,"eighty":-1.024563,"marketCap":797148139},{"date":"2024-05-03","current":-3.914171,"twenty":-5.747015,"median":-2.67051,"eighty":-1.024563,"marketCap":930531583},{"date":"2024-05-10","current":-4.070008,"twenty":-5.747015,"median":-2.677955,"eighty":-1.024563,"marketCap":887770529},{"date":"2024-05-17","current":-4.280677,"twenty":-5.747015,"median":-2.707429,"eighty":-1.024563,"marketCap":933722706},{"date":"2024-05-24","current":-3.557965,"twenty":-5.747015,"median":-2.758292,"eighty":-1.024563,"marketCap":776081210},{"date":"2024-05-31","current":-3.493594,"twenty":-5.747015,"median":-2.77973,"eighty":-1.024563,"marketCap":762040267},{"date":"2024-06-07","current":-3.578447,"twenty":-5.747015,"median":-2.815111,"eighty":-1.024563,"marketCap":780548783},{"date":"2024-06-14","current":-3.847635,"twenty":-5.749661,"median":-2.834523,"eighty":-1.023648,"marketCap":839265454},{"date":"2024-06-21","current":-3.622337,"twenty":-5.752307,"median":-2.848224,"eighty":-1.022734,"marketCap":790122153},{"date":"2024-06-28","current":-3.739375,"twenty":-5.768397,"median":-2.880489,"eighty":-1.021569,"marketCap":815651141},{"date":"2024-07-05","current":-3.584299,"twenty":-5.768397,"median":-2.895281,"eighty":-1.021569,"marketCap":781825233},{"date":"2024-07-12","current":-3.789116,"twenty":-5.768397,"median":-2.923562,"eighty":-1.021569,"marketCap":826500960},{"date":"2024-07-15","current":-4.064156,"twenty":-5.768397,"median":-2.928473,"eighty":-1.021569,"marketCap":886494080},{"date":"2024-08-02","current":-4.76346,"twenty":-5.806354,"median":-2.976634,"eighty":-1.016023,"marketCap":1039029779},{"date":"2024-08-09","current":-4.235889,"twenty":-5.806354,"median":-2.999708,"eighty":-1.017309,"marketCap":966015590},{"date":"2024-08-16","current":-4.179858,"twenty":-5.806354,"median":-3.018168,"eighty":-1.041063,"marketCap":953237606},{"date":"2024-08-23","current":-4.297522,"twenty":-5.806354,"median":-3.024321,"eighty":-1.080768,"marketCap":980071372},{"date":"2024-08-30","current":-4.202271,"twenty":-5.806354,"median":-3.053981,"eighty":-1.091308,"marketCap":958348800},{"date":"2024-09-06","current":-3.773639,"twenty":-5.806354,"median":-3.075086,"eighty":-1.113319,"marketCap":860597222},{"date":"2024-09-13","current":-5.799133,"twenty":-5.806354,"median":-3.0797,"eighty":-1.130096,"marketCap":1322521344},{"date":"2024-09-20","current":-7.533366,"twenty":-5.863774,"median":-3.10739,"eighty":-1.155212,"marketCap":1718021700},{"date":"2024-09-27","current":-7.719827,"twenty":-5.96033,"median":-3.127388,"eighty":-1.161894,"marketCap":1760545101},{"date":"2024-10-04","current":-7.994339,"twenty":-5.993368,"median":-3.159693,"eighty":-1.172472,"marketCap":1823149047},{"date":"2024-10-11","current":-7.364969,"twenty":-6.086671,"median":-3.175076,"eighty":-1.179321,"marketCap":1679618050},{"date":"2024-10-18","current":-8.121552,"twenty":-6.144411,"median":-3.213534,"eighty":-1.191464,"marketCap":1852160631},{"date":"2024-10-25","current":-7.820258,"twenty":-6.191496,"median":-3.307371,"eighty":-1.196968,"marketCap":1783448984},{"date":"2024-10-31","current":-7.42188,"twenty":-6.228864,"median":-3.355313,"eighty":-1.200789,"marketCap":1692596916},{"date":"2024-11-08","current":-8.272199,"twenty":-6.334811,"median":-3.392854,"eighty":-1.206301,"marketCap":1886516455},{"date":"2024-11-15","current":-6.667719,"twenty":-6.407343,"median":-3.426563,"eighty":-1.212218,"marketCap":1714163845},{"date":"2024-11-22","current":-6.045316,"twenty":-6.407343,"median":-3.453285,"eighty":-1.219655,"marketCap":1554154096},{"date":"2024-11-29","current":-6.639988,"twenty":-6.507267,"median":-3.490528,"eighty":-1.224951,"marketCap":1707034697},{"date":"2024-12-06","current":-6.048398,"twenty":-6.524235,"median":-3.515423,"eighty":-1.230585,"marketCap":1554946223},{"date":"2024-12-13","current":-5.543081,"twenty":-6.524235,"median":-3.558169,"eighty":-1.241784,"marketCap":1425037318},{"date":"2024-12-20","current":-5.771089,"twenty":-6.526193,"median":-3.568206,"eighty":-1.25264,"marketCap":1483654751},{"date":"2024-12-27","current":-6.110022,"twenty":-6.526193,"median":-3.582617,"eighty":-1.259182,"marketCap":1570788773},{"date":"2025-01-03","current":-6.088453,"twenty":-6.526193,"median":-3.602105,"eighty":-1.268646,"marketCap":1565243880},{"date":"2025-01-10","current":-5.9005,"twenty":-6.526193,"median":-3.612259,"eighty":-1.276888,"marketCap":1516924105},{"date":"2025-01-17","current":-5.256529,"twenty":-6.526193,"median":-3.647416,"eighty":-1.292889,"marketCap":1351369463},{"date":"2025-01-24","current":-5.780333,"twenty":-6.526193,"median":-3.689243,"eighty":-1.301593,"marketCap":1486031133},{"date":"2025-01-31","current":-6.187052,"twenty":-6.526193,"median":-3.707456,"eighty":-1.331747,"marketCap":1590591959},{"date":"2025-02-07","current":-5.703303,"twenty":-6.526193,"median":-3.754986,"eighty":-1.3811,"marketCap":1466227946},{"date":"2025-02-14","current":-5.244204,"twenty":-6.526193,"median":-3.774325,"eighty":-1.422341,"marketCap":1348200953},{"date":"2025-02-21","current":-5.120956,"twenty":-6.526193,"median":-3.806672,"eighty":-1.431046,"marketCap":1316515855},{"date":"2025-02-28","current":-4.486636,"twenty":-6.526193,"median":-3.847635,"eighty":-1.45435,"marketCap":1211162901},{"date":"2025-03-07","current":-4.793428,"twenty":-6.526193,"median":-3.865607,"eighty":-1.469442,"marketCap":1293981006},{"date":"2025-03-14","current":-4.772298,"twenty":-6.526193,"median":-3.913546,"eighty":-1.491451,"marketCap":1288277059},{"date":"2025-03-21","current":-4.62439,"twenty":-6.526193,"median":-3.933837,"eighty":-1.538755,"marketCap":1248349434},{"date":"2025-03-28","current":-4.428185,"twenty":-6.526193,"median":-3.958655,"eighty":-1.554954,"marketCap":1195384216},{"date":"2025-04-04","current":-3.818442,"twenty":-6.526193,"median":-3.961657,"eighty":-1.608794,"marketCap":1030784617},{"date":"2025-04-11","current":-3.444144,"twenty":-6.526193,"median":-3.958822,"eighty":-1.69092,"marketCap":929743279},{"date":"2025-04-17","current":-3.818442,"twenty":-6.526193,"median":-3.964491,"eighty":-1.722306,"marketCap":1030784617},{"date":"2025-04-25","current":-4.093128,"twenty":-6.526193,"median":-3.973947,"eighty":-1.772869,"marketCap":1104935922},{"date":"2025-05-02","current":-4.147462,"twenty":-6.526193,"median":-3.992023,"eighty":-1.832913,"marketCap":1119603213},{"date":"2025-05-09","current":-3.382036,"twenty":-6.526193,"median":-4.001263,"eighty":-1.992998,"marketCap":1042746092},{"date":"2025-05-16","current":-3.339695,"twenty":-6.526193,"median":-4.001263,"eighty":-2.085196,"marketCap":1029691368},{"date":"2025-05-23","current":-3.617562,"twenty":-6.526193,"median":-4.001263,"eighty":-2.116091,"marketCap":1115362995},{"date":"2025-05-30","current":-3.696952,"twenty":-6.526193,"median":-4.001263,"eighty":-2.144327,"marketCap":1139840603},{"date":"2025-06-06","current":-3.768404,"twenty":-6.526193,"median":-4.001263,"eighty":-2.159668,"marketCap":1161870450},{"date":"2025-06-13","current":-4.146832,"twenty":-6.526193,"median":-4.013153,"eighty":-2.167663,"marketCap":1278547047},{"date":"2025-06-20","current":-3.969526,"twenty":-6.526193,"median":-4.04507,"eighty":-2.175685,"marketCap":1223880390},{"date":"2025-06-27","current":-3.850441,"twenty":-6.526193,"median":-4.04507,"eighty":-2.20038,"marketCap":1187163978},{"date":"2025-07-03","current":-4.146832,"twenty":-6.526193,"median":-4.05379,"eighty":-2.218304,"marketCap":1278547047},{"date":"2025-07-11","current":-4.533199,"twenty":-6.526193,"median":-4.069032,"eighty":-2.248468,"marketCap":1397671405},{"date":"2025-07-18","current":-4.512028,"twenty":-6.526193,"median":-4.080673,"eighty":-2.282243,"marketCap":1391144043},{"date":"2025-07-25","current":-4.628468,"twenty":-6.526193,"median":-4.101856,"eighty":-2.286158,"marketCap":1427044534},{"date":"2025-08-01","current":-4.636407,"twenty":-6.526193,"median":-4.118225,"eighty":-2.307932,"marketCap":1429492295},{"date":"2025-08-08","current":-3.923371,"twenty":-6.526193,"median":-4.133024,"eighty":-2.325465,"marketCap":1349878959},{"date":"2025-08-15","current":-4.376707,"twenty":-6.526193,"median":-4.136329,"eighty":-2.337048,"marketCap":1505854084},{"date":"2025-08-22","current":-4.27702,"twenty":-6.526193,"median":-4.147462,"eighty":-2.361841,"marketCap":1471555889},{"date":"2025-08-29","current":-4.376707,"twenty":-6.526193,"median":-4.168652,"eighty":-2.376767,"marketCap":1505854084},{"date":"2025-09-05","current":-4.424176,"twenty":-6.526193,"median":-4.18015,"eighty":-2.389755,"marketCap":1522186558},{"date":"2025-09-12","current":-4.664222,"twenty":-6.526193,"median":-4.192603,"eighty":-2.396249,"marketCap":1604776848},{"date":"2025-09-19","current":-4.657101,"twenty":-6.526193,"median":-4.195824,"eighty":-2.428718,"marketCap":1602326807},{"date":"2025-09-26","current":-4.528924,"twenty":-6.526193,"median":-4.207874,"eighty":-2.457956,"marketCap":1558226069},{"date":"2025-10-03","current":-5.036885,"twenty":-6.526193,"median":-4.227177,"eighty":-2.493657,"marketCap":1732995660},{"date":"2025-10-10","current":-5.17693,"twenty":-6.526193,"median":-4.249976,"eighty":-2.544309,"marketCap":1781179799},{"date":"2025-10-17","current":-5.461768,"twenty":-6.526193,"median":-4.265153,"eighty":-2.583273,"marketCap":1879181439},{"date":"2025-10-24","current":-5.238645,"twenty":-6.526193,"median":-4.274943,"eighty":-2.616669,"marketCap":1802413488},{"date":"2025-10-31","current":-5.616055,"twenty":-6.526193,"median":-4.286808,"eighty":-2.648973,"marketCap":1932265660},{"date":"2025-11-07","current":-8.691746,"twenty":-6.532719,"median":-4.297522,"eighty":-2.672233,"marketCap":2624655220},{"date":"2025-11-14","current":-9.004649,"twenty":-6.61756,"median":-4.307348,"eighty":-2.694968,"marketCap":2719142807},{"date":"2025-11-21","current":-9.314391,"twenty":-6.667719,"median":-4.324567,"eighty":-2.722986,"marketCap":2812675975},{"date":"2025-11-28","current":-10.101389,"twenty":-6.750911,"median":-4.339545,"eighty":-2.764347,"marketCap":3050326575},{"date":"2025-12-05","current":-10.259421,"twenty":-6.92654,"median":-4.357717,"eighty":-2.795113,"marketCap":3098047579},{"date":"2025-12-12","current":-10.294188,"twenty":-7.091408,"median":-4.371341,"eighty":-2.828742,"marketCap":3108546200},{"date":"2025-12-19","current":-9.987606,"twenty":-7.386046,"median":-4.377056,"eighty":-2.847415,"marketCap":3015967452},{"date":"2025-12-26","current":-10.202529,"twenty":-7.466402,"median":-4.388994,"eighty":-2.876643,"marketCap":3080868018},{"date":"2026-01-02","current":-9.835896,"twenty":-7.616048,"median":-4.400442,"eighty":-2.892382,"marketCap":2970155288},{"date":"2026-01-09","current":-9.586206,"twenty":-7.70141,"median":-4.407562,"eighty":-2.922793,"marketCap":2894756102},{"date":"2026-01-16","current":-10.439577,"twenty":-7.793476,"median":-4.428185,"eighty":-2.938176,"marketCap":3152449524},{"date":"2026-01-23","current":-10.167762,"twenty":-7.820258,"median":-4.434796,"eighty":-2.952021,"marketCap":3070369397},{"date":"2026-01-30","current":-10.610251,"twenty":-7.835524,"median":-4.443223,"eighty":-2.992017,"marketCap":3203988208},{"date":"2026-02-06","current":-9.219572,"twenty":-7.903951,"median":-4.464082,"eighty":-3.015861,"marketCap":2784043373},{"date":"2026-02-13","current":-9.086825,"twenty":-7.994339,"median":-4.486636,"eighty":-3.024321,"marketCap":2743957730},{"date":"2026-02-20","current":-8.881384,"twenty":-8.029354,"median":-4.509382,"eighty":-3.041243,"marketCap":2681920424},{"date":"2026-02-27","current":-8.215343,"twenty":-8.087496,"median":-4.528924,"eighty":-3.061241,"marketCap":2814584815},{"date":"2026-03-06","current":-8.61862,"twenty":-8.121932,"median":-4.544661,"eighty":-3.076624,"marketCap":2952747836},{"date":"2026-03-13","current":-8.475424,"twenty":-8.146856,"median":-4.570056,"eighty":-3.10694,"marketCap":2903688682},{"date":"2026-03-20","current":-8.305378,"twenty":-8.181811,"median":-4.586562,"eighty":-3.124593,"marketCap":2845430936},{"date":"2026-03-27","current":-8.412776,"twenty":-8.205354,"median":-4.612002,"eighty":-3.153539,"marketCap":2882225302},{"date":"2026-04-02","current":-5.712931,"twenty":-8.205354,"median":-4.623067,"eighty":-3.173538,"marketCap":1957255834},{"date":"2026-04-10","current":-4.588244,"twenty":-8.205354,"median":-4.62439,"eighty":-3.208445,"marketCap":1571937061},{"date":"2026-04-17","current":-4.37345,"twenty":-8.205354,"median":-4.62439,"eighty":-3.252365,"marketCap":1498348330},{"date":"2026-04-24","current":-4.281111,"twenty":-8.205354,"median":-4.62439,"eighty":-3.311279,"marketCap":1466712980},{"date":"2026-05-01","current":-4.055473,"twenty":-8.205354,"median":-4.62439,"eighty":-3.355313,"marketCap":1389409063},{"date":"2026-05-08","current":-4.859454,"twenty":-8.205354,"median":-4.628617,"eighty":-3.390768,"marketCap":1752270580},{"date":"2026-05-15","current":-4.98237,"twenty":-8.205354,"median":-4.646829,"eighty":-3.39556,"marketCap":1796592718},{"date":"2026-05-22","current":-5.417415,"twenty":-8.205354,"median":-4.664222,"eighty":-3.426902,"marketCap":1953465694},{"date":"2026-05-29","current":-5.343917,"twenty":-8.207352,"median":-4.684228,"eighty":-3.448785,"marketCap":1926963050},{"date":"2026-06-05","current":-5.074424,"twenty":-8.205354,"median":-4.704574,"eighty":-3.482864,"marketCap":1829786690},{"date":"2026-06-12","current":-4.94274,"twenty":-8.205354,"median":-4.747973,"eighty":-3.505298,"marketCap":1782302787},{"date":"2026-06-18","current":-5.117298,"twenty":-8.205354,"median":-4.76346,"eighty":-3.543336,"marketCap":1845246566},{"date":"2026-06-26","current":-5.325543,"twenty":-8.207352,"median":-4.780161,"eighty":-3.559611,"marketCap":1920337389},{"date":"2026-07-02","current":-5.659346,"twenty":-8.207352,"median":-4.791097,"eighty":-3.569084,"marketCap":2040703563},{"date":"2026-07-10","current":-6.186082,"twenty":-8.207352,"median":-4.81436,"eighty":-3.583626,"marketCap":2230639176},{"date":"2026-07-17","current":-5.521537,"twenty":-8.207352,"median":-4.837109,"eighty":-3.602254,"marketCap":1991011106},{"date":"2026-07-24","current":-5.898214,"twenty":-8.207352,"median":-4.86517,"eighty":-3.614384,"marketCap":2126837155},{"date":"2026-07-31","current":-6.094209,"twenty":-8.20935,"median":-4.890591,"eighty":-3.62457,"marketCap":2197510871},{"date":"2026-08-07","current":-6.423499,"twenty":-8.20935,"median":-4.908353,"eighty":-3.65085,"marketCap":2485727121},{"date":"2026-08-14","current":-6.437892,"twenty":-8.20935,"median":-4.939896,"eighty":-3.688093,"marketCap":2491296995},{"date":"2026-08-21","current":-7.172731,"twenty":-8.20935,"median":-4.958634,"eighty":-3.69854,"marketCap":2775660590},{"date":"2026-08-28","current":-6.991217,"twenty":-8.20935,"median":-4.991739,"eighty":-3.723907,"marketCap":2705419383},{"date":"2026-09-04","current":-6.721874,"twenty":-8.20935,"median":-5.013114,"eighty":-3.75938,"marketCap":2601190496},{"date":"2026-09-11","current":-6.525722,"twenty":-8.20935,"median":-5.034958,"eighty":-3.771637,"marketCap":2525284676},{"date":"2026-09-18","current":-6.420327,"twenty":-8.20935,"median":-5.053426,"eighty":-3.791843,"marketCap":2484499459},{"date":"2026-09-25","current":-6.048516,"twenty":-8.20935,"median":-5.092799,"eighty":-3.81629,"marketCap":2340618277},{"date":"2026-10-02","current":-5.559599,"twenty":-8.20935,"median":-5.109117,"eighty":-3.841366,"marketCap":2151420188},{"date":"2026-10-08","current":-5.351736,"twenty":-8.20935,"median":-5.120956,"eighty":-3.854569,"marketCap":2070982677}],"updateTime":1791552209316},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRDN\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633578941","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Henry Schein (HSIC), Viridian Therapeutics (VRDN) and Q32 Bio (QTTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633578941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633578941?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:50","pubTimestamp":1777992613,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Henry Schein (HSIC), Viridian Therapeutics (VRDN) and Q32 Bio (QT...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-henry-schein-hsic-viridian-therapeutics-vrdn-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-henry-schein-hsic-viridian-therapeutics-vrdn-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","HCSG","LABU","VRDN","QTTB","LU0029874061.USD","BK4137","BK4175","XLV","BK4581","BK4139","BK4585","HSIC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453269","title":"Viridian Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453269","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453269?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:10","pubTimestamp":1777986653,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryViridian Therapeutics Inc VRDN.OQ reported a quarterly adjusted loss of 90 cents per share for the quarter en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I1QK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633910000","title":"Viridian eye disease drug surpasses expectations in late-stage trial; shares soar","url":"https://stock-news.laohu8.com/highlight/detail?id=2633910000","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633910000?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:18","pubTimestamp":1777983510,"startTime":"0","endTime":"0","summary":"UPDATE 2-Viridian eye disease drug surpasses expectations in late-stage trial; shares soarUpdates shares, adds analyst comment in paragraphs 6 & 7, CEO comment in 8By Siddhi Mahatole. CEO Steve Mahoney said the drug, if approved, could offer a convenient, at-home auto-injector in as few as three doses, helping expand the market.Thyroid eye disease is an autoimmune condition causing inflammation, swelling and fat expansion behind the eyes, often leading to bulging, pain, redness and double vision.Active TED is marked by acute inflammation and pain lasting months to years, while chronic TED is the stable phase in which symptoms such as bulging eyes or double vision persist without active swelling.  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL4N41I11A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B2B36J28.USD","LU0889565916.HKD","LU0289739699.SGD","LU0868494617.USD","LU2112291526.USD","AMGN","LU1571399168.USD","BK4588","LU0109394709.USD","LU2242646821.SGD","LU2242652126.USD","LU2468319806.SGD","LU1023059063.AUD","BK4585","LU0122379950.USD","VRDN","LU1983299246.USD","BK4533","LU1057294990.SGD","BK4581","IE0009355771.USD","LU0058720904.USD","IE0002141913.USD","LU1061106388.HKD","LU0320765992.SGD","SG9999001440.SGD","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4566","BK4599","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633910095","title":"Viridian Therapeutics Shares Jump 26% Premarket After Co's Eye Disease Drug Meets Main of a Late-Stage Trial in Chronic Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2633910095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633910095?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:17","pubTimestamp":1777983435,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41I15T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633691712","title":"Viridian announces REVEAL-2 phase 3 study met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2633691712","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633691712?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:38","pubTimestamp":1777981098,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics (VRDN) announced positive topline data from the REVEAL-2 phase 3 clinical trial of elegrobart in patients with chronic thyroi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viridian-announces-reveal-2-phase-3-study-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viridian-announces-reveal-2-phase-3-study-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633140659","title":"Viridian Q1 FY26 net loss widens to $104.9 million; revenue rises to $141,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2633140659","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633140659?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:09","pubTimestamp":1777979361,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics posted a wider net loss of $104.9 million, versus $86.9 million a year earlier.R&D expenses edged up to $77.6 million from $76.8 million.SG&A expenses more than doubled to $38.7 million from $17.1 million, due to preparatory commercial activities for veligrotug, including higher personnel-related costs from headcount increases.Cash, cash equivalents, and marketable securities fell to $762.2 million as of March 31, 2026, from $874.7 million at end-2025; veligrotug faces an FDA PDUFA target action date of June 30, 2026 with launch preparations completed, while Viridian plans to submit an elegrobart BLA in Q1 2027 after positive REVEAL-1 and REVEAL-2 phase 3 topline data.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLZRW7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633240914","title":"Viridian says elegrobart meets Phase 3 endpoint in chronic thyroid eye disease trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2633240914","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633240914?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:06","pubTimestamp":1777979160,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics reported positive topline results from REVEAL-2, a Phase 3 trial of subcutaneous elegrobart in chronic thyroid eye disease; results were announced today ahead of a conference call.Trial met primary endpoint, showing clear improvement versus placebo in eye bulging; one dosing schedule also showed improvement in double vision versus placebo.Safety profile was broadly consistent with prior studies, with low rates of hearing-related side effects and no treatment-related serious adverse events reported.Biologics License Application submission for elegrobart remains on track for Q1 2027, positioning it as a potential at-home autoinjector option if cleared by regulators.Veligrotug, Viridian lead thyroid eye disease program, remains under FDA Priority Review with a PDUFA target action date of June 30, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLc0p43f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914660","title":"BRIEF-Viridian Therapeutics Q1 Revenue USD 6 Thousand Vs. IBES Estimate USD 27.5 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914660","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914660?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:01","pubTimestamp":1777978905,"startTime":"0","endTime":"0","summary":"BRIEF-Viridian Therapeutics Q1 Revenue USD 6 Thousand Vs. IBES Estimate USD 27.5 Thousand\n\n\nMay 05 (Reuters) - Viridian Therapeutics Q1 net income USD -104.901 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXDEF8C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914749","title":"Corrected-Viridian Therapeutics Q1 Revenue USD 141 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914749?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:01","pubTimestamp":1777978860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXDEF8C2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633891100","title":"Viridian Therapeutics Q1 Revenue USD 6 Thousand VS. Ibes Estimate USD 27.5 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2633891100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633891100?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:01","pubTimestamp":1777978860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXDEF8C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914837","title":"Viridian Therapeutics Inc - Elegrobart Bla Submission on Track for Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914837","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914837?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA8QKFFB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914313","title":"Viridian Therapeutics Inc - Veligrotug FDA Priority Review With Pdufa Target Date June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914313?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA8QKFFB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633911007","title":"Viridian Therapeutics Inc - Reveal-2 Trial Meets Primary Endpoint With Highly Statistically Significant Treatment Effect","url":"https://stock-news.laohu8.com/highlight/detail?id=2633911007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633911007?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA8QKFFB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633143699","title":"Viridian Therapeutics Inc - Elegrobart Generally Well Tolerated With Low Rates of Hearing Impairment","url":"https://stock-news.laohu8.com/highlight/detail?id=2633143699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633143699?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA8QKFFB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633114649","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 06:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2633114649","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633114649?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:55","pubTimestamp":1777978500,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 06:55 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nAQN2LXN20:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660694","title":"Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632660694?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:30","pubTimestamp":1777588210,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AptarGroup (ATR) and Viridian Therapeutics (VRDN). AptarGroup (AT...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aptargroup-atr-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aptargroup-atr-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATR","BK4137","BK4126","XLV","LABU","BK4581","BK4139","LU0029874061.USD","BK4585","BK4588","HCSG","XBI","LU0128526141.USD","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629080095","title":"Need To Know: The Consensus Just Cut Its Viridian Therapeutics, Inc. (NASDAQ:VRDN) Estimates For 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629080095","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629080095?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:08","pubTimestamp":1776766134,"startTime":"0","endTime":"0","summary":"One thing we could say about the analysts on Viridian Therapeutics, Inc. ( NASDAQ:VRDN ) - they aren't optimistic...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/need-to-know-the-consensus-just-cut-its-viridian-therapeutic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/need-to-know-the-consensus-just-cut-its-viridian-therapeutic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IYW","PSQ","QQQY","TQQQ","QID","MNQmain","ONEQ","QQQJ","GPIQ","QLD","FTEC","SQQQ","QQQM",".IXIC","QDTE","NVIW.SI","NDX","JEPQ","QQQA","QYLG","BK4139","QQQ","NQmain","VRDN","TQQY","QQQE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628623947","title":"Will Amgen’s Subcutaneous Tepezza Success Reshape Viridian Therapeutics' (VRDN) Thyroid Eye Disease Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2628623947","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628623947?lang=en_us&edition=fundamental","pubTime":"2026-04-19 17:06","pubTimestamp":1776589616,"startTime":"0","endTime":"0","summary":"In recent days, Viridian Therapeutics has come under renewed attention after Amgen reported positive Phase 3 results for a subcutaneous version of Tepezza in moderate to severe active thyroid eye disease, raising questions about future treatment options in this space.\nThis competing clinical success places a spotlight on how Viridian’s own thyroid eye disease pipeline could fit into an evolving treatment landscape and patient preference profile.\nNext, we’ll examine how Amgen’s subcutaneous...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/will-amgens-subcutaneous-tepezza-success-reshape-viridian-th","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/will-amgens-subcutaneous-tepezza-success-reshape-viridian-th","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0002141913.USD","IE00B4R5TH58.HKD","LU2242652126.USD","BK4566","IE00BFTCPJ56.SGD","BK4599","IE00BJJMRZ35.SGD","LU2468319806.SGD","BK4534","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","AMGN","LU0122379950.USD","LU0868494617.USD","IE0009355771.USD","VRDN","BK4581","BK4533","LU1983299246.USD","BK4585","LU2242646821.SGD","BK4139","LU2112291526.USD","BK4588","LU0889565916.HKD","LU0109394709.USD","LU1061106388.HKD","LU1571399168.USD","LU0058720904.USD","LU2089984988.USD","SG9999001440.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628205170","title":"Viridian Therapeutics announces annual shareholder meeting webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2628205170","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628205170?lang=en_us&edition=fundamental","pubTime":"2026-04-17 20:02","pubTimestamp":1776427330,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics will hold its annual stockholders meeting online on June 2, 2026.Items up for a vote include election of two Class II directors to terms running to 2029.Shareholders will also vote on ratifying KPMG as independent auditor for fiscal 2026.Advisory votes will cover executive compensation plus preferred frequency of future say-on-pay votes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viridian Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL65M6Dn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627455812","title":"A Look At Viridian Therapeutics (VRDN) Valuation After Positive REVEAL-1 Phase 3 Elegrobart Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2627455812","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627455812?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:12","pubTimestamp":1776078744,"startTime":"0","endTime":"0","summary":"Phase 3 REVEAL-1 results put elegrobart in focus\nViridian Therapeutics (VRDN) just reported statistically significant, positive topline data from its Phase 3 REVEAL-1 trial of elegrobart in active thyroid eye disease, a material update that reshapes how you might look at the stock.\nSee our latest analysis for Viridian Therapeutics.\nThe REVEAL-1 update lands after a volatile stretch, with the share price at $14.95, a 7 day share price return of 7.55% but a 90 day share price return of 53.27%,...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/a-look-at-viridian-therapeutics-vrdn-valuation-after-positiv-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/a-look-at-viridian-therapeutics-vrdn-valuation-after-positiv-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","VRDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":80,"code":"91000000","status":"200"}]}}